May 09th 2026 | Dorint Hotel Dresden | Dresden, Germany Exciting Updates from the 11th Dresden Liquor Symposium On May 9, 2026, leading experts from across Germany and beyond will gather at the Dorint Hotel Dresden for the 11th Dresden Liquor Symposium one of the most important events for the latest developments in cerebrospinal fluid […]

May 14 – 17, 2026 | Prague Congress Centre | Prague, Czech Republic Join Us at the 15th International Congress on Autoimmunity in Prague We are excited to announce that Medipan GmbH & GA Generic Assays GmbH will be participating in the 15th International Congress on Autoimmunity, taking place from May 14-17, 2026, in Prague, […]

Primary sclerosing cholangitis (PSC) is a chronic, progressive inflammatory disease affecting the bile ducts and often leading to fibrosis, cirrhosis, and eventually liver failure. PSC also carries an increased risk of hepatobiliary malignancies, particularly cholangiocarcinoma. Despite significant research efforts, PSC remains difficult to diagnose and manage because its pathogenesis is not fully understood and reliable […]

April 24–25, 2026 | 21st Annual Congress of the German Rheumatologists Association (BDRh)| Estrel Berlin On April 24 and 25, 2026, the 21st Annual Congress of the German Rheumatologists Association (BDRh) will take place for the first time at Estrel Berlin. Under the motto “Sharing Knowledge – Securing the Future”, the congress brings together rheumatologists, […]

Understanding Normal Analytical Variation In diagnostic testing, it is not uncommon to observe small differences when the same sample is measured repeatedly. Such variations are expected and reflect the inherent characteristics of the assay, even under well-controlled laboratory conditions. Diagnostic assays rely on complex biological, chemical, and technical processes. Each step introduces a degree of […]

Antinuclear antibody (ANA) testing by indirect immunofluorescence assay (IFA) on HEp-2 cells remains the gold standard screening method for systemic autoimmune rheumatic diseases (SARD), including systemic lupus erythematosus, systemic sclerosis and Sjögren’s syndrome. However, manual interpretation of ANA HEp-2 IFA patterns is time-consuming, operator-dependent and subject to inter-observer variability. A recent large-scale study published in […]

Celebrating 8 Years of Excellence in the CAP Antinuclear Antibody (ANA) Survey! We are proud to announce an important milestone in our quality journey: Eight consecutive years of successful participation in the Antinuclear Antibody (ANA) Survey organized by the College of American Pathologists (CAP). Eight Years of Commitment to Quality For eight years, our laboratory […]

Atypical hemolytic uremic syndrome (aHUS), also known as complement-mediated thrombotic microangiopathy (CM-TMA), is a rare but life-threatening condition caused by dysregulation of the alternative complement pathway. Among the known etiologies, autoantibodies against complement factor H (anti-factor H) play a critical role, accounting for approximately 10% of cases. Accurate laboratory detection of these antibodies is essential, […]

In regions affected by recurrent cholera outbreaks, overlapping infectious diseases can obscure the diagnosis of post-infectious autoimmune conditions. We recently collaborated in the publication describing a pediatric case from Yemen that illustrates how Guillain–Barré Syndrome (GBS) can emerge during a cholera outbreak, highlighting the critical role of Campylobacter jejuni infection and anti-ganglioside antibody testing 1. […]

February 10 – 13, 2026 | Dubai World Trade Centre | Dubai, UAE Medipan at the WHX Labs Dubai 2026 formerly Medlab Middle East Medipan is proud to announce our participation in WHX Labs Dubai 2026 (formerly Medlab Middle East), one of the leading global exhibitions for laboratory diagnostics, healthcare technologies, and life sciences innovations. […]